comprehensive -WSS

comprehensive

author：comprehensive 2025-08-26 23:47:12 - browse：5

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Medical leaders decry Supreme Court decision on affirmative action

WSS

EU regulator recommends expanding Mounjaro approval to obesity

Think you might have Covid

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Wildfire smoke exposes gaps in outdoor worker protections

Drug repurposing or repositioning? The language matters

Alkermes shareholders re

Wikipedia

comprehensive

explore

Virginia high school admissions case could be legal follow

Medicare Advantage today, explained in one chart

In Memoriam: Notable people who died in 2023

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

New air purifier tech could be key to improving indoor air quality

Sports medicine is finally prioritizing gender equality

Bright Health sells Medicare Advantage business to Molina

Alkermes shareholders re

The high cost of giving birth even with insurance

The surgeon had a dilemma only a Nazi medical text could resolve

Wikipedia

Apple is now the first public company to be valued at $3 trillion

BioMarin wins approval for gene therapy to treat hemophilia A

The tragedy of Johnson & Johnson’s Covid vaccine

Francis Collins on trust in science and how Covid communications failed

Readout Newsletter: Merck, J&J, and long Covid

Cancer drug shortages should be causing more outrage

focus

hotspot

leisure time

entertainment